According to FutureWise analysis, the market for Genomics in 2023 is US$ 46.2 billion, and is expected to reach US$ 119.55 billion by 2031 at a CAGR of 12.62%.

Genomics encompasses the study of an organism's complete or partial genetic and epigenetic sequences, aiming to unravel their structure, function, and downstream biological effects. In the context of health, genomics delves into the intricate molecular mechanisms and interactions between genetic information, health interventions, and environmental factors that influence disease. This extends beyond human genomics, considering the dynamic connections between human genomes and those of various organisms, spanning plants, vectors, and pathogens. Genomics plays a pivotal role in public health across diverse species. Distinguished from genetics, which focuses on individual genes, genomics investigates all genes and their intricate relationships, illuminating their collective impact on an organism's growth and development. The potential of genomics for public health is profound, offering avenues to address global health disparities by providing cost-effective means to prevent, diagnose, and treat prevalent diseases in developing nations. While the full extent of genomics' role in healthcare is still unfolding, its future promises innovative approaches to managing complex conditions, emphasizing the need to ensure equitable distribution of benefits worldwide and to maintain a balance between traditional medical practices and emerging genomic possibilities.

FutureWise Market Research has published a report that provides an insightful analysis of Genomics Market trends affecting overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes the stature of key manufacturers operational in this industry.

By the end of the forecast period, FutureWise research analysts project that the Genomics Market will experience significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market and further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific, Inc. 
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Danaher Corporation 
  • Waters Corporation
  • Bio-Rad Laboratories, Inc. 
  • Bruker Corporation
  • GE Healthcare
  • Perkinelmer, Inc.
  • Luminex Corporation 
  • Creative Proteomics
  • Promega Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in the Genomics Market

  • In March 2023, Inc (US) unveiled Connected Insights, a cloud-based software enabling comprehensive analysis of clinical next-generation sequencing data, particularly beneficial for genomic profiling (CGP) in advanced tumors and whole-genome sequencing for rare diseases.
  • Thermo Fisher Scientific, Inc. (US) launched the TrueMark STI Select Panel in February 2023, offering a polymerase chain reaction (PCR) test designed for research purposes. The panel detects Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium.
  • Eppendorf AG (Germany) expanded its production capacity by initiating a new production site in Shanghai, China, as of February 2023. This expansion aims to enhance manufacturing capabilities and accommodate growing demands in the genomics sector.
  • Oxford Nanopore Technologies (UK) and 10x Genomics (US) joined forces in October 2022, establishing a collaboration to streamline the sequencing of full-length transcripts using Oxford Nanopore devices. This partnership aims to advance single-read sequencing efficiency and accessibility.

By Product & Services

  • Consumables and Reagents
  • Services
  • Instruments
  • Software

By Technology

  • Sequencing
  • PCR
  • Flow Cytometry
  • Microarrays
  • Other Technologies 

By Application

  • Drug Discovery and Development
  • Diagnostics
  • Agriculture and Animal Research
  • Other Applications

By Study Type

  • Functional Genomics
  • Biomarker Discovery
  • Pathway Analysis
  • Epigenomics
  • Other Study Types

By End-User

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Other End-users 

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. This is due to factors like rising chronic disease cases, government investments in research, heightened consumer awareness, advanced healthcare infrastructure, and vital technological advancements. For example, the US invested significantly in genomic analysis to combat COVID-19 variants, enhancing genomic sequencing capabilities. Additionally, by product & service, consumables and reagents accounted for the largest market share in the global market in 2022. The demand for consumables in genomic systems is surging due to the growing number of genomic tests globally. This trend is a significant driver of market growth. Major players continuously introducing nucleic acid extraction kits and reagents fuel revenue growth in this segment. For example, MGI Tech Co., Ltd. introduced the HotMPS high throughput screening kit and instrument in Germany in June 2022. Moreover, in 2022, by technology, the sequencing segment accounted for the largest market share, and by study type, functional genomics is the highest market share holder with 37.1% share in the global market.

Drivers for Genomics Market

Rising cancer incidence rates are pivotal in propelling the genomics market forward. The expanding utilization of next-generation sequencing in cancer research has revolutionized diagnosis and treatment approaches. Genomics has revolutionized cancer diagnostics by enabling non-invasive blood sample-based methods and enhancing inherited cancer screening tests. This profound impact on cancer detection and management is a crucial driver behind the market's growth trajectory. Furthermore, incorporating artificial intelligence (AI) into genomics has recently experienced significant advancement. The vast data generated by sequencing technologies are rapidly and accurately analyzed through AI algorithms. This intricate analysis aids in swiftly identifying genetic variations linked to specific diseases, enabling timely interventions. AI's capabilities extend further to tailoring personalized treatment strategies for patients. This synergy between AI and genomics empowers healthcare professionals to prescribe the most effective and targeted therapies. As AI-driven insights become increasingly accurate and reliable, this symbiotic relationship presents a significant avenue for the market's expansion.

Restraints for Genomics Market

The realm of genomics intricately weaves together complex processes encompassing recombinant DNA technology, DNA sequencing methodologies, and bioinformatics. These elements merge to facilitate the analysis, assembly, and understanding of genomes' intricate structure and functionality. The expertise of proficient genetics professionals becomes pivotal in navigating this complex web of intricacies. Unfortunately, a need for more skilled genetics experts presents a significant hurdle, impeding the expansion of the market. This shortage has, regrettably, resulted in misinterpretations and flawed observations during genetic research and testing, spotlighting the substantial challenge posed by the insufficiency of trained professionals. Genomics investigations entail a tapestry of intricate procedures, from gene editing and sequencing to amplification and multiplexing. These processes demand highly sophisticated instruments, including microarray equipment, PCR instruments, centrifuges, sequencers, analyzers, and liquid handling devices. The delicate and precise handling of these sensitive instruments is a paramount necessity, emerging as a formidable hindrance to the market's growth.

Opportunities for Genomics Market

The expansion of genomics research and development is a pivotal opportunity for the growth of the genomics market. Notably, in July 2022, the World Health Organization (WHO) launched its Science Council of Experts, focusing on fostering equitable genomics expansion. This initiative aims to enhance access to genomic technologies, particularly in low and middle-income countries, addressing gaps in financing, materials, skilled professionals, and laboratory infrastructure. These collective efforts are poised to propel market growth significantly. Additionally, the application of genomics in diagnosing rare disorders is proving transformative. Through extensive genetic testing, the swift and cost-effective understanding of genomes has revolutionized rare disorder diagnosis. This advancement enhances diagnosis and treatment options for patients with rare diseases and gives patients insights into the potential risks for future generations. An example of this lies in the realm of genomics, aiding in the diagnosis and treatment of rare disorders, thereby underpinning the expansion of the market.

Trends for Genomics Market

The genomics field is undergoing a revolutionary transformation towards personalized medicine, leveraging an individual's genetic data to tailor medical strategies. This enduring trend fuels the advancement of customized therapies and medications tailored to a person's unique genetic composition. Concurrently, the ascent of Direct-to-Consumer (DTC) Genetic Testing is rapidly gaining traction, empowering individuals to directly access insights about their genetic heritage, health susceptibilities, and well-being through at-home genetic testing kits. This trend is positioned for sustained expansion with growing consumer awareness and evolving regulations. Furthermore, integrating genomic data into electronic health records (EHRs) and other medical information is gaining greater importance. By amalgamating genomic insights with a patient's medical background, a holistic understanding of their health is synthesized, amplifying the precision of diagnoses and treatment choices. For instance, an individual's genetic profile could unearth a predisposition to a specific ailment, facilitating early interventions and personalized therapeutic strategies to enhance health outcomes.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • FutureWise research report will help you understand the growth prospects, key trends, and data points affecting the market's growth.
  • A detailed review of strategies being opted by the players in this market, and a thorough market share registered by the key companies globally as well as on a regional basis.
  • To provide with an exhaustive analysis on the of Genomics Market By Product & services, By Technology, By Application, By Study Type, By End-User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Genomics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Genomics Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Genomics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Genomics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Genomics Market, By Product & Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Consumables and Reagents
        2. Services
        3. Instruments
        4. Software

  • 8.   Genomics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sequencing
        2. PCR
        3. Flow Cytometry
        4. Microarrays
        5. Other Technologies

  • 9.  Genomics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drug Discovery and Development
        2. Diagnostics
        3. Agriculture and Animal Research
        4. Other Applications

  • 10.   Genomics Market, By Study Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Functional Genomics
        2. Biomarker Discovery
        3. Pathway Analysis
        4. Epigenomics
        5. Other Study Types

  • 11.   Genomics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Clinics
        2. Academic and research institutes
        3. Pharmaceutical & Biotechnology Companies
        4. Other End Users

  • 12.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Thermo Fisher Scientific, Inc.
                  1.1. Company Overview (HQ, Business Segments, Employee Strength)
                  1.2. Product Portfolio
                  1.3. SWOT Analysis
                  1.4. Financial Overview
                  1.5. Strategic Overview
        2. Agilent Technologies, Inc
                  2.1. Company Overview (HQ, Business Segments, Employee Strength)
                  2.2. Product Portfolio
                  2.3. SWOT Analysis
                  2.4. Financial Overview
                  2.5. Strategic Overview
        3. Merck KGaA
                  3.1. Company Overview (HQ, Business Segments, Employee Strength)
                  3.2. Product Portfolio
                  3.3. SWOT Analysis
                  3.4. Financial Overview
                  3.5. Strategic Overview
        4. Danaher Corporation
                  4.1. Company Overview (HQ, Business Segments, Employee Strength)
                  4.2. Product Portfolio
                  4.3. SWOT Analysis
                  4.4. Financial Overview
                  4.5. Strategic Overview
        5. Waters Corporation
                  5.1. Company Overview (HQ, Business Segments, Employee Strength)
                  5.2. Product Portfolio
                  5.3. SWOT Analysis
                  5.4. Financial Overview
                  5.5. Strategic Overview
        6. Bio-Rad Laboratories, Inc.
                  6.1. Company Overview (HQ, Business Segments, Employee Strength)
                  6.2. Product Portfolio
                  6.3. SWOT Analysis
                  6.4. Financial Overview
                  6.5. Strategic Overview
        7. Bruker Corporation
                  7.1. Company Overview (HQ, Business Segments, Employee Strength)
                  7.2. Product Portfolio
                  7.3. SWOT Analysis
                  7.4. Financial Overview
                  7.5. Strategic Overview
        8. GE Healthcare
                  8.1. Company Overview (HQ, Business Segments, Employee Strength)
                  8.2. Product Portfolio
                  8.3. SWOT Analysis
                  8.4. Financial Overview
                  8.5. Strategic Overview
        9. Perkinelmer Inc.
                  9.1. Company Overview (HQ, Business Segments, Employee Strength)
                  9.2. Product Portfolio
                  9.3. SWOT Analysis
                  9.4. Financial Overview
                  9.5. Strategic Overview
        10. Luminex Corporation
                  10.1. Company Overview (HQ, Business Segments, Employee Strength)
                  10.2. Product Portfolio
                  10.3. SWOT Analysis
                  10.4. Financial Overview
                  10.5. Strategic Overview
        11. Creative Proteomics
                  11.1. Company Overview (HQ, Business Segments, Employee Strength)
                  11.2. Product Portfolio
                  11.3. SWOT Analysis
                  11.4. Financial Overview
                  11.5. Strategic Overview
        12. Promega Corporation.
                  12.1. Company Overview (HQ, Business Segments, Employee Strength)
                  12.2. Product Portfolio
                  12.3. SWOT Analysis
                  12.4. Financial Overview
                  12.5. Strategic Overview

  • 19.  Pre and Post COVID-19 Impact
    •     1. Positive influence on the healthcare industry
          2. The financial disruption of the manufacturing sector
          3. Impact of COVID-19 on emerging companies
          4. Significant mandates in the healthcare regulations initiated by administrations
          5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

Our Clients